Literature DB >> 24138116

Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A.

Rajesh Singh1, Pranav Gupta, Praveen K Sharma, Edwin W Ades, Susan K Hollingshead, Shailesh Singh, James W Lillard.   

Abstract

Pneumococcal surface adhesin A (PsaA) is a multifunctional lipoprotein known to bind nasopharyngeal epithelial cells, and is significantly involved in bacterial adherence and virulence. Identification of PsaA peptides that optimally bind human leucocyte antigen (HLA) and elicit a potent immune response would be of great importance to vaccine development. However, this is hindered by the multitude of HLA polymorphisms in humans. To identify the conserved immunodominant epitopes, we used an experimental dataset of 28 PsaA synthetic peptides and in silico methods to predict specific peptide-binding to HLA and murine MHC class II molecules. We also characterized spleen and cervical lymph node (CLN) -derived T helper (Th) lymphocyte cytokine responses to these peptides after Streptococcus pneumoniae strain EF3030 challenge in mice. Individual, yet overlapping, peptides 15 amino acids in length revealed residues of PsaA that consistently caused the highest interferon-γ, interleukin-2 (IL-2), IL-5 and IL-17 responses and proliferation as well as moderate IL-10 and IL-4 responses by ex vivo re-stimulated splenic and CLN CD4⁺ T cells isolated from S. pneumoniae strain EF3030-challenged F1 (B6 × BALB/c) mice. In silico analysis revealed that peptides from PsaA may interact with a broad range of HLA-DP, -DQ and -DR alleles, due in part to regions lacking β-turns and asparagine endopeptidase sites. These data suggest that Th cell peptides (7, 19, 20, 22, 23 and 24) screened for secondary structures and MHC class II peptide-binding affinities can elicit T helper cytokine and proliferative responses to PsaA peptides.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  MHC; Streptococcus pneumoniae; T helper type 1/2 cytokine; peptide vaccine

Mesh:

Substances:

Year:  2014        PMID: 24138116      PMCID: PMC3956426          DOI: 10.1111/imm.12194

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  51 in total

1.  Control of antigen presentation by a single protease cleavage site.

Authors:  A N Antoniou; S L Blackwood; D Mazzeo; C Watts
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

2.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

3.  Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Authors:  D E Briles; E Ades; J C Paton; J S Sampson; G M Carlone; R C Huebner; A Virolainen; E Swiatlo; S K Hollingshead
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 4.  MHC structure and autoimmune T cell repertoire development.

Authors:  W M Ridgway; C G Fathman
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

5.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

6.  Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-γ-mediated immunity.

Authors:  Juan M Marqués; Analía Rial; Natalia Muñoz; Francois-Xavier Pellay; Laurye Van Maele; Hélène Léger; Teresa Camou; Jean-Claude Sirard; Arndt Benecke; José A Chabalgoity
Journal:  Immunobiology       Date:  2011-11-23       Impact factor: 3.144

7.  T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization.

Authors:  Kristin L Moffitt; Todd M Gierahn; Ying-jie Lu; Paulo Gouveia; Mark Alderson; Jessica Baker Flechtner; Darren E Higgins; Richard Malley
Journal:  Cell Host Microbe       Date:  2011-02-17       Impact factor: 21.023

8.  Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.

Authors:  Jieh-Juen Yu; Tatareddy Goluguri; M Neal Guentzel; James P Chambers; Ashlesh K Murthy; Karl E Klose; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

9.  Allergic airway inflammation and susceptibility to pneumococcal pneumonia in a murine model with real-time in vivo evaluation.

Authors:  C-I Kang; M S Rouse; R Patel; H Kita; Y J Juhn
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

10.  Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae.

Authors:  Yuan Li; Todd Gierahn; Claudette M Thompson; Krzysztof Trzciński; Christopher B Ford; Nicholas Croucher; Paulo Gouveia; Jessica B Flechtner; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2012-11-08       Impact factor: 6.823

View more
  4 in total

1.  Immune Memory After Respiratory Infection With Streptococcus pneumoniae Is Revealed by in vitro Stimulation of Murine Splenocytes With Inactivated Pneumococcal Whole Cells: Evidence of Early Recall Responses by Transcriptomic Analysis.

Authors:  Isabelle Franco Moscardini; Francesco Santoro; Monica Carraro; Alice Gerlini; Fabio Fiorino; Chiara Germoni; Samaneh Gholami; Elena Pettini; Donata Medaglini; Francesco Iannelli; Gianni Pozzi
Journal:  Front Cell Infect Microbiol       Date:  2022-06-20       Impact factor: 6.073

2.  A chitosan-based nanosystem as pneumococcal vaccine delivery platform.

Authors:  Sandra Robla; Maruthi Prasanna; Rubén Varela-Calviño; Cyrille Grandjean; Noemi Csaba
Journal:  Drug Deliv Transl Res       Date:  2021-03-02       Impact factor: 4.617

3.  IL17eScan: A Tool for the Identification of Peptides Inducing IL-17 Response.

Authors:  Sudheer Gupta; Parul Mittal; Midhun K Madhu; Vineet K Sharma
Journal:  Front Immunol       Date:  2017-10-31       Impact factor: 7.561

4.  Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation.

Authors:  Aline Pillot; Alain Defontaine; Amina Fateh; Annie Lambert; Maruthi Prasanna; Mathieu Fanuel; Muriel Pipelier; Noemi Csaba; Typhaine Violo; Emilie Camberlein; Cyrille Grandjean
Journal:  Front Chem       Date:  2019-11-01       Impact factor: 5.221

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.